Prospective, randomized phase III study comparing two intensified regimens (methotrexate/vinblastine/doxorubicin hydrochloride/cisplatin MVAC versus gemcitabine/cisplatin) in patients with inoperable or recurrent urothelial cancer

dc.creator	Bamias, A.	en
dc.creator	Karadimou, A.	en
dc.creator	Lampaki, S.	en
dc.creator	Aravantinos, G.	en
dc.creator	Xanthakis, I.	en
dc.creator	Papandreou, C.	en
dc.creator	Lainakis, G.	en
dc.creator	Zagouri, F.	en
dc.creator	Soupos, N.	en
dc.creator	Kostouros, E.	en
dc.creator	Samantas, E.	en
dc.creator	Hatzimouratidis, C.	en
dc.creator	Konstantinidis, C.	en
dc.creator	Deliveliotis, C.	en
dc.creator	Pectasides, D. G.	en
dc.creator	Fountzilas, G.	en
dc.creator	Dimopoulos, M. A.	en
dc.creator	Hellenic Cooperative Oncology, Grp	en
dc.date.accessioned	2015-11-23T10:23:32Z
dc.date.available	2015-11-23T10:23:32Z
dc.date.issued	2011
dc.identifier.issn	0732-183X
dc.identifier.uri	http://hdl.handle.net/11615/26136
dc.source	Journal of Clinical Oncology	en
dc.source.uri	<Go to ISI>://WOS:000208880300552
dc.subject	Oncology	en
dc.title	Prospective, randomized phase III study comparing two intensified regimens (methotrexate/vinblastine/doxorubicin hydrochloride/cisplatin MVAC versus gemcitabine/cisplatin) in patients with inoperable or recurrent urothelial cancer	en
dc.type	journalArticle	en

Dateien zu dieser Ressource

Dateien	Größe	Format	Anzeige
Zu diesem Dokument gibt es keine Dateien.